立即术后cfDNA提升预测了机器人辅助激进前列腺切除术后的疼痛
Noritaka Ishii1, Tohru Yoneyama2, Satoko Minakawa3,4
1Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
概括
手术后即时的无细胞DNA (cfDNA) 水平有效预测机器人辅助激进前列腺切除术后的疼痛严重程度. 这种生物标志物可以为接受手术的患者提供个性化疼痛管理策略.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 生物化学 生化学
背景情况:
- 无细胞DNA (cfDNA) 显示出作为外科手术侵入性的生物标志物的潜力.
- 对于术后结果,特别是疼痛的cfDNA的预测价值需要进一步调查.
研究的目的:
- 评估机器人辅助激进前列腺切除术 (RARP) 后立即测量的cfDNA水平是否可以预测术后疼痛和手术压力.
- 将cfDNA与用于疼痛预测的常规标记器进行比较.
主要方法:
- 对80名RARP患者的回顾性分析.
- 在手术前和手术后立即测量cfDNA.
- 使用数值评分表 (NRS) 评估术后疼痛,并与cfDNA水平和常规压力标志物相关联.
主要成果:
- 在中度至重度疼痛 (NRS ≥4) 的患者中观察到较高的cfDNA比率.
- 升高的cfDNA (≥2.00) 与中度至重度术后疼痛的几率增加有关.
- 像CRP和白细胞计数等常规标志物与疼痛严重程度或cfDNA水平没有相关性.
结论:
- 立即术后cfDNA是一种敏感的生物标志物,用于预测RARP后的疼痛严重程度.
- 这种cfDNA比率可能有助于开发个性化的术后疼痛管理.
- 建议对这些发现进行前性验证.
相关概念视频
Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...


